Under What Circumstances Can a Private Qui Tam Plaintiff Overrule Government Agency Experts' Use of Administrative Discretion to File False Claims Act Actions in the Post-Escobar FCA World?

Published date11 October 2017
Law FirmAkin Gump Strauss Hauer & Feld LLP
AuthorRobert Salcido
Subject MatterDOJ,CMS,Medical Devices,FDA,Qui Tam,Department of the Interior,DCAA,Warning Labels,Materiality,Genentech,Side Effects,Relators,ANSI,Government Agencies,False Claims Act (FCA),Universal Health Services Inc v United States ex rel Escobar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT